[Treatment of patients with Ewing's sarcoma, reticulosarcoma and myeloma disease].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000671:Amputation, Surgical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D008070:Lipopolysaccharides / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy*; D008297:Male; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D012512:Sarcoma, Ewing / Q000401:mortality / Q000628:therapy*
D000276:Adjuvants, Immunologic; D008070:Lipopolysaccharides; C009136:pyrogenal
Lechenie bol'nykh sarkomoĭ Iuinga, retikulosarkomoĭ i mielomnoĭ bolezn'iu.